PharmAbs
PharmAbs develops antibody and nanobody discovery and delivery technologies for therapeutic and diagnostic applications.
PharmAbs focuses on the development of novel antibody/nanobody discovery and delivery technologies and innovative antibody-based therapeutics and diagnostics. The company translates basic scientific innovations from universities into diagnostic/therapeutic solutions for personalized medicine that can be implemented in the clinic or commercialized by third parties.
Key People
- Hans Deckmyn - Co-founder
- Paul Declerck - Co-founder
- Xavier Bossuyt - Co-founder
Marc Jacquemin - Co-founder- Karen Van Hoorelbeke - Co-founder